REGN
Regeneron Pharmaceuticals, Inc. β’ Healthcare (#5 of 11)
$777.25
+4.61 (+0.60%)
View:
Close:$777.25
Vol:NORMAL(55%ile)
Ratio:0.97x
|RSI:56(Neutral)
MACD:β
β₯75%25-75%<25%
Vol.%
Sector Rotation
2026-04-01(10/10)
20d Strength (bar)
Strong (Β±4%)
Normal (-2~+3%)
5d Strength (normal: -1~+1%)
Relative Strength Trajectory
5d Strength
10d Strength
20d Strength
NASDAQ
10d early: 3~5%|20d confirm: 4~8.5%|>8.5% exhaustion
Analyst Actions
NEUTRALβ²0 UpβΌ0 Down2 Hold
Mar 31Truist Securities
βBuy
Mar 6Barclays
βOverweight
Mar 2RBC Capital
βSector Perform
Price Targets
(60d mean: $850, +9.3%)β²1 RaisesβΌ1 Lowers+2.7% avg
Mar 31Truist Securities
$818β$801-2.1%
Mar 6Barclays
$923New
Mar 2RBC Capital
$745β$765+2.7%
Trade Setup
Entry$777.25
Target$817.27 (+5.1%)
Stop$737.23
R/R1.00
Risk-5.1%
Conv37 (LOW)
Size11 shares ($8,550)
Risk Metrics
Sharpe (20d)
-0.45Losing
Volatility (20d)
28.3%Normal
Beta (60d)
0.85Average
Alpha (20d)
+2.9%Moderate+
News Analysis
EN
δΈ
ν
ζ₯
No analysis record found.